Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 211,363 $ 130,572
Short-term restricted cash 162 105
Short-term investments 23,864 0
Accounts receivable, net 137,065 119,724
Inventory 146,431 131,703
Prepaid expenses and other current assets 19,739 22,000
Total current assets 538,624 404,104
Long-term restricted cash 894 1,061
Property and equipment, net 64,136 60,924
Leased right-of-use assets 33,154 27,269
Intangible assets, net 127,928 152,540
Goodwill 306,739 306,668
Deferred tax assets 81,762 89,168
Other long-term assets 27,456 8,650
Total assets 1,180,693 1,050,384
Current liabilities:    
Accounts payable 73,140 52,976
Accrued price protection liability 110,553 40,509
Accrued expenses and other current liabilities 93,507 57,268
Accrued compensation 38,881 56,642
Total current liabilities 316,081 207,395
Long-term lease liabilities 27,838 24,640
Long-term debt 246,450 306,153
Other long-term liabilities 20,727 22,998
Total liabilities 611,096 561,186
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 78,333 shares issued and outstanding at June 30, 2022 and 76,778 shares issued and outstanding December 31, 2021 8 8
Additional paid-in capital 677,395 657,485
Accumulated other comprehensive income (loss) (2,938) 2,125
Accumulated deficit (104,868) (170,420)
Total stockholders’ equity 569,597 489,198
Total liabilities and stockholders’ equity $ 1,180,693 $ 1,050,384